메뉴 건너뛰기




Volumn 188, Issue 8, 2013, Pages 901-906

Theophylline

Author keywords

Adenosine receptor; Histone deacetylase; Methylxanthine; Phosphodiesterase

Indexed keywords

ADENOSINE RECEPTOR; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; HISTONE DEACETYLASE 2; INTERLEUKIN 10; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; THEOPHYLLINE;

EID: 84886434565     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201302-0388PP     Document Type: Review
Times cited : (363)

References (54)
  • 2
    • 0029072842 scopus 로고
    • Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants
    • Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 1995;8:637-642.
    • (1995) Eur Respir J , vol.8 , pp. 637-642
    • Rabe, K.F.1    Magnussen, H.2    Dent, G.3
  • 3
    • 0028431503 scopus 로고
    • Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition
    • Dent G, Giembycz MA, Rabe KF, Wolf B, Barnes PJ, Magnussen H. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. Am J Respir Cell Mol Biol 1994; 10:565-572.
    • (1994) Am J Respir Cell Mol Biol , vol.10 , pp. 565-572
    • Dent, G.1    Giembycz, M.A.2    Rabe, K.F.3    Wolf, B.4    Barnes, P.J.5    Magnussen, H.6
  • 4
    • 70349174810 scopus 로고    scopus 로고
    • Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease
    • Polosa R, Blackburn MR. Adenosine receptors as targets for therapeutic intervention in asthma and chronic obstructive pulmonary disease. Trends Pharmacol Sci 2009;30:528-535.
    • (2009) Trends Pharmacol Sci , vol.30 , pp. 528-535
    • Polosa, R.1    Blackburn, M.R.2
  • 5
    • 0029833439 scopus 로고    scopus 로고
    • Anti-inflammatory effects of theophylline: Modulation of cytokine production
    • Mascali JJ, Cvietusa P, Negri J, Borish L. Anti-inflammatory effects of theophylline: modulation of cytokine production. Ann Allergy Asthma Immunol 1996;77:34-38.
    • (1996) Ann Allergy Asthma Immunol , vol.77 , pp. 34-38
    • Mascali, J.J.1    Cvietusa, P.2    Negri, J.3    Borish, L.4
  • 6
    • 0034750233 scopus 로고    scopus 로고
    • Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages
    • Oliver B, Tomita K, Keller A, Caramori G, Adcock I, Chung KF, Barnes PJ, Lim S. Low-dose theophylline does not exert its anti-inflammatory effects in mild asthma through upregulation of interleukin-10 in alveolar macrophages. Allergy 2001;56:1087-1090.
    • (2001) Allergy , vol.56 , pp. 1087-1090
    • Oliver, B.1    Tomita, K.2    Keller, A.3    Caramori, G.4    Adcock, I.5    Chung, K.F.6    Barnes, P.J.7    Lim, S.8
  • 8
    • 0034253389 scopus 로고    scopus 로고
    • The downregulation of Bcl-2 expression is necessary for theophyllineinduced apoptosis of eosinophil
    • Chung IY, Nam-Kung EK, Lee NM, Chang HS, Kim DJ, Kim YH, Park CS. The downregulation of Bcl-2 expression is necessary for theophyllineinduced apoptosis of eosinophil. Cell Immunol 2000;203:95-102.
    • (2000) Cell Immunol , vol.203 , pp. 95-102
    • Chung, I.Y.1    Nam-Kung, E.K.2    Lee, N.M.3    Chang, H.S.4    Kim, D.J.5    Kim, Y.H.6    Park, C.S.7
  • 9
    • 0032838480 scopus 로고    scopus 로고
    • Apoptosis of eosinophils and lymphocytes in allergic inflammation
    • Ohta K, Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999;104:14-21.
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 14-21
    • Ohta, K.1    Yamashita, N.2
  • 11
    • 0037173056 scopus 로고    scopus 로고
    • A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression
    • Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 2002;99:8921-8926.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 8921-8926
    • Ito, K.1    Lim, S.2    Caramori, G.3    Cosio, B.4    Chung, K.F.5    Adcock, I.M.6    Barnes, P.J.7
  • 12
    • 4544379912 scopus 로고    scopus 로고
    • Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages
    • Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004;200:689-695.
    • (2004) J Exp Med , vol.200 , pp. 689-695
    • Cosio, B.G.1    Tsaprouni, L.2    Ito, K.3    Jazrawi, E.4    Adcock, I.M.5    Barnes, P.J.6
  • 16
    • 0029018483 scopus 로고
    • Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation
    • Zhang ZY, Kaminsky LS. Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem Pharmacol 1995; 50:205-211.
    • (1995) Biochem Pharmacol , vol.50 , pp. 205-211
    • Zhang, Z.Y.1    Kaminsky, L.S.2
  • 17
    • 0029788377 scopus 로고    scopus 로고
    • Drug interactions with azithromycin and the macrolides: An overview
    • Nahata M. Drug interactions with azithromycin and the macrolides: an overview. J Antimicrob Chemother 1996;37:133-142.
    • (1996) J Antimicrob Chemother , vol.37 , pp. 133-142
    • Nahata, M.1
  • 18
    • 0024211843 scopus 로고
    • Dose response relation to oral theophylline in severe chronic obstructive airways disease
    • Chrystyn H, Mulley BA, Peake MD. Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ 1988;297:1506-1510.
    • (1988) BMJ , vol.297 , pp. 1506-1510
    • Chrystyn, H.1    Mulley, B.A.2    Peake, M.D.3
  • 19
    • 0037445151 scopus 로고    scopus 로고
    • Theophylline: New perspectives for an old drug
    • Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-818.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 813-818
    • Barnes, P.J.1
  • 20
    • 0028344025 scopus 로고
    • Antiinflammatory effects of low-dose oral theophylline in atopic asthma
    • Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Antiinflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-1008.
    • (1994) Lancet , vol.343 , pp. 1006-1008
    • Sullivan, P.1    Bekir, S.2    Jaffar, Z.3    Page, C.4    Jeffery, P.5    Costello, J.6
  • 26
    • 0033952050 scopus 로고    scopus 로고
    • Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis
    • Hidi R, Timmermans S, Liu E, Schudt C, Dent G, Holgate ST, Djukanović R. Phosphodiesterase and cyclic adenosine monophosphate- dependent inhibition of T-lymphocyte chemotaxis. Eur Respir J 2000;15:342-349.
    • (2000) Eur Respir J , vol.15 , pp. 342-349
    • Hidi, R.1    Timmermans, S.2    Liu, E.3    Schudt, C.4    Dent, G.5    Holgate, S.T.6    Djukanović, R.7
  • 29
    • 0023923899 scopus 로고
    • Aminophylline and the respiratory muscles: An alternative view
    • Moxham J. Aminophylline and the respiratory muscles: an alternative view. Clin Chest Med 1988;9:325-336.
    • (1988) Clin Chest Med , vol.9 , pp. 325-336
    • Moxham, J.1
  • 30
    • 84874146341 scopus 로고    scopus 로고
    • Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma
    • Nair P, Milan SJ, Rowe BH. Addition of intravenous aminophylline to inhaled beta(2)-agonists in adults with acute asthma. Cochrane Database Syst Rev 2012;12:CD002742.
    • (2012) Cochrane Database Syst Rev , vol.12
    • Nair, P.1    Milan, S.J.2    Rowe, B.H.3
  • 31
    • 84921537327 scopus 로고    scopus 로고
    • Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
    • Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators. Cochrane Database Syst Rev 2005;CD001276.
    • (2005) Cochrane Database Syst Rev
    • Mitra, A.1    Bassler, D.2    Goodman, K.3    Lasserson, T.J.4    Ducharme, F.M.5
  • 32
    • 24744471804 scopus 로고    scopus 로고
    • Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
    • Duffy N, Walker P, Diamantea F, Calverley PM, Davies L. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Thorax 2005;60:713-717.
    • (2005) Thorax , vol.60 , pp. 713-717
    • Duffy, N.1    Walker, P.2    Diamantea, F.3    Calverley, P.M.4    Davies, L.5
  • 33
    • 0141566276 scopus 로고    scopus 로고
    • Methylxanthines for exacerbations of chronic obstructive pulmonary disease: Meta-analysis of randomised trials
    • Barr RG, Rowe BH, Camargo CA Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials. BMJ 2003;327:643.
    • (2003) BMJ , vol.327 , pp. 643
    • Barr, R.G.1    Rowe, B.H.2    Camargo Jr., C.A.3
  • 34
    • 84921431228 scopus 로고    scopus 로고
    • Long acting beta-agonists versus theophylline for maintenance treatment of asthma
    • Wilson AJ, Gibson PG, Coughlan J. Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2000;2:CD001281.
    • (2000) Cochrane Database Syst Rev , vol.2
    • Wilson, A.J.1    Gibson, P.G.2    Coughlan, J.3
  • 37
    • 0030719429 scopus 로고    scopus 로고
    • A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma
    • Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-1418.
    • (1997) N Engl J Med , vol.337 , pp. 1412-1418
    • Evans, D.J.1    Taylor, D.A.2    Zetterstrom, O.3    Chung, K.F.4    O'connor, B.J.5    Barnes, P.J.6
  • 42
    • 0024399378 scopus 로고
    • A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease
    • Murciano D, Auclair MH, Pariente R, Aubier M. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Engl J Med 1989;320:1521-1525.
    • (1989) N Engl J Med , vol.320 , pp. 1521-1525
    • Murciano, D.1    Auclair, M.H.2    Pariente, R.3    Aubier, M.4
  • 44
    • 33746877055 scopus 로고    scopus 로고
    • Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year
    • Zhou Y, Wang X, Zeng X, Qiu R, Xie J, Liu S, Zheng J, Zhong N, Ran P. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. Respirology 2006;11:603-610.
    • (2006) Respirology , vol.11 , pp. 603-610
    • Zhou, Y.1    Wang, X.2    Zeng, X.3    Qiu, R.4    Xie, J.5    Liu, S.6    Zheng, J.7    Zhong, N.8    Ran, P.9
  • 45
    • 66049156186 scopus 로고    scopus 로고
    • Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease
    • Cosio BG, Iglesias A, Rios A, Noguera A, Sala E, Ito K, Barnes PJ, Agusti A. Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease. Thorax 2009;64:424-429.
    • (2009) Thorax , vol.64 , pp. 424-429
    • Cosio, B.G.1    Iglesias, A.2    Rios, A.3    Noguera, A.4    Sala, E.5    Ito, K.6    Barnes, P.J.7    Agusti, A.8
  • 46
    • 77953310216 scopus 로고    scopus 로고
    • Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD
    • Ford PA, Durham AL, Russell REK, Gordon F, Adcock IM, Barnes PJ. Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. Chest 2010;137:1338-1344.
    • (2010) Chest , vol.137 , pp. 1338-1344
    • Ford, P.A.1    Durham, A.L.2    Russell, R.E.K.3    Gordon, F.4    Adcock, I.M.5    Barnes, P.J.6
  • 48
    • 0021910016 scopus 로고
    • Bronchodilator actions of xanthine derivatives administered by inhalation in asthma
    • Cushley MJ, Holgate ST. Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax 1985;40:176-179.
    • (1985) Thorax , vol.40 , pp. 176-179
    • Cushley, M.J.1    Holgate, S.T.2
  • 49
    • 84860279670 scopus 로고    scopus 로고
    • Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: A pilot study
    • Voduc N, Alvarez GG, Amjadi K, Tessier C, Sabri E, Aaron SD. Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study. Int J Chron Obstruct Pulmon Dis 2012;7:245-252.
    • (2012) Int J Chron Obstruct Pulmon Dis , vol.7 , pp. 245-252
    • Voduc, N.1    Alvarez, G.G.2    Amjadi, K.3    Tessier, C.4    Sabri, E.5    Aaron, S.D.6
  • 50
    • 70349378493 scopus 로고    scopus 로고
    • Doxofylline: A promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease
    • Shukla D, Chakraborty S, Singh S, Mishra B. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2009;10: 2343-2356.
    • (2009) Expert Opin Pharmacother , vol.10 , pp. 2343-2356
    • Shukla, D.1    Chakraborty, S.2    Singh, S.3    Mishra, B.4
  • 53
    • 84055207673 scopus 로고    scopus 로고
    • PDE4: A novel target in the treatment of chronic obstructive pulmonary disease
    • Michalski JM, Golden G, Ikari J, Rennard SI. PDE4: a novel target in the treatment of chronic obstructive pulmonary disease. Clin Pharmacol Ther 2012;91:134-142.
    • (2012) Clin Pharmacol Ther , vol.91 , pp. 134-142
    • Michalski, J.M.1    Golden, G.2    Ikari, J.3    Rennard, S.I.4
  • 54
    • 70350345805 scopus 로고    scopus 로고
    • Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
    • Banner KH, Press NJ. Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease. Br J Pharmacol 2009;157:892-906.
    • (2009) Br J Pharmacol , vol.157 , pp. 892-906
    • Banner, K.H.1    Press, N.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.